Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study

Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant depression: a naturalistic feasibility study

Abstract Background Ketamine is a promising therapy for treatment-resistant depression due to its rapid onset, although benefits are often transitory, with patients needing maintenance therapy to prevent relapse. Most data supporting ketamine for treatment-resistant depression refers to the intraven...

Full description

Saved in:
Bibliographic Details
Main Authors: Katelyn Halpape, Raelle Pashovitz, Annabelle Wanson, Monika Hooper, Evyn M. Peters
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Psychiatry
Subjects:
Ketamine
Major depressive disorder
Mood disorders
Observational study
Online Access:https://doi.org/10.1186/s12888-024-06448-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12888-024-06448-x

Similar Items